Literature DB >> 26294735

Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.

Andrea Visentin1, Nicolò Compagno1, Francesco Cinetto1, Silvia Imbergamo2, Renato Zambello1, Francesco Piazza1, Gianpietro Semenzato1, Livio Trentin3, Carlo Agostini3.   

Abstract

Entities:  

Keywords:  CLL; hypogammaglobulinemia; immunoglobulin replacement therapy; infections; secondary hypogammaglobulinemia

Mesh：

Substances：

Year:  2015        PMID： 26294735      PMCID： PMC4666345          DOI： 10.3324/haematol.2015.126763

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.

Authors:  J Moreira; K G Rabe; J R Cerhan; N E Kay; J W Wilson; T G Call; J F Leis; D F Jelinek; S M Schwager; D A Bowen; C A Hanson; S L Slager; T D Shanafelt
Journal:  Leukemia       Date:  2012-07-11       Impact factor: 11.528

2.  Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.

Authors:  Sameer A Parikh; Jose F Leis; Kari G Chaffee; Timothy G Call; Curtis A Hanson; Wei Ding; Asher A Chanan-Khan; Deborah Bowen; Michael Conte; Susan Schwager; Susan L Slager; Daniel L Van Dyke; Diane F Jelinek; Neil E Kay; Tait D Shanafelt
Journal:  Cancer       Date:  2015-04-30       Impact factor: 6.860

3.  Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.

Authors:  David Oscier; Claire Dearden; Efrem Eren; Efrem Erem; Christopher Fegan; George Follows; Peter Hillmen; Tim Illidge; Estella Matutes; Don W Milligan; Andrew Pettitt; Anna Schuh; Jennifer Wimperis
Journal:  Br J Haematol       Date:  2012-10-11       Impact factor: 6.998

4.  Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia.

Authors:  Jane A Freeman; Kyle R Crassini; O Giles Best; Cecily J Forsyth; Naomi J Mackinlay; Ping Han; William Stevenson; Stephen P Mulligan
Journal:  Leuk Lymphoma       Date:  2012-09-08

Review 5.  Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.

Authors:  Michael Hallek
Journal:  Am J Hematol       Date:  2015-05       Impact factor: 10.047

6.  The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.

Authors:  Sebastian Francis; Mamatha Karanth; Guy Pratt; Jane Starczynski; Laura Hooper; Chris Fegan; Chris Pepper; David Valcarcel; Donald W Milligan; Julio Delgado
Journal:  Cancer       Date:  2006-09-01       Impact factor: 6.860

7.  Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.

Authors:  Manfred Hensel; Martin Kornacker; Sophie Yammeni; Gerlinde Egerer; Anthony D Ho
Journal:  Br J Haematol       Date:  2003-08       Impact factor: 6.998

8.  Guidelines on the use of intravenous immune globulin for hematologic conditions.

Authors:  David Anderson; Kaiser Ali; Victor Blanchette; Melissa Brouwers; Stephen Couban; Paula Radmoor; Lothar Huebsch; Heather Hume; Anne McLeod; Ralph Meyer; Catherine Moltzan; Susan Nahirniak; Stephen Nantel; Graham Pineo; Gail Rock
Journal:  Transfus Med Rev       Date:  2007-04

Review 9.  Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation.

Authors:  Pia Raanani; Anat Gafter-Gvili; Mical Paul; Isaac Ben-Bassat; Leonard Leibovici; Ofer Shpilberg
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 10.  Immunoglobulin replacement therapy in secondary hypogammaglobulinemia.

Authors:  Nicolò Compagno; Giacomo Malipiero; Francesco Cinetto; Carlo Agostini
Journal:  Front Immunol       Date:  2014-12-08       Impact factor: 7.561
View more
  14 in total

1.  Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.

Authors:  Chiara Briani; Andrea Visentin; Alessandro Salvalaggio; Silvia Imbergamo; Francesco Piazza; Mario Cacciavillani; Marta Campagnolo; Federica Frezzato; Gianpietro Semenzato; Livio Trentin
Journal:  Haematologica       Date:  2016-12-07       Impact factor: 9.941

2.  IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.

Authors:  Ganchimeg Ishdorj; Erin Streu; Pascal Lambert; Harbhajan S Dhaliwal; Salaheddin M Mahmud; Spencer B Gibson; Versha Banerji; Aaron J Marshall; James B Johnston
Journal:  Blood Adv       Date:  2019-07-23

3.  Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes.

Authors:  Firas El Chaer; Dimpy P Shah; Joumana Kmeid; Ella J Ariza-Heredia; Chitra M Hosing; Victor E Mulanovich; Roy F Chemaly
Journal:  Cancer       Date:  2017-02-08       Impact factor: 6.860

4.  Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study.

Authors:  Andrea Visentin; Vincenzo Nasillo; Monia Marchetti; Isacco Ferrarini; Rossella Paolini; Rosaria Sancetta; Gian Matteo Rigolin; Francesca Cibien; Marcello Riva; Chiara Briani; Serena Marinello; Francesco Piazza; Filippo Gherlinzoni; Mauro Krampera; Renato Bassan; Antonio Cuneo; Mario Luppi; Gianpietro Semenzato; Roberto Marasca; Livio Trentin
Journal:  Hemasphere       Date:  2020-06-08

5.  Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia.

Authors:  David E Spaner; Robertson Venema; Justin Huang; Peter Norris; Alan Lazarus; Guizhi Wang; Yonghong Shi
Journal:  EBioMedicine       Date:  2018-08-30       Impact factor: 8.143

6.  Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.

Authors:  Francesco Cinetto; Raffaella Neri; Fabrizio Vianello; Andrea Visentin; Gregorio Barilà; Sabrina Gianese; Alison Lanciarotta; Cinzia Milito; Marcello Rattazzi; Francesco Piazza; Livio Trentin; Renato Zambello; Carlo Agostini; Riccardo Scarpa
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

Review 7.  Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.

Authors:  Valentina Griggio; Francesca Perutelli; Chiara Salvetti; Elia Boccellato; Mario Boccadoro; Candida Vitale; Marta Coscia
Journal:  Front Immunol       Date:  2020-11-18       Impact factor: 7.561

8.  An Eschar-like souvenir from a journey to Colombia: Ecthyma gangrenosum as a differential diagnosis of tropical diseases in immunocompromised patients - a case report.

Authors:  Gabriela M Wiedemann; Jochen Schneider; Mareike Verbeek; Björn Konukiewitz; Christoph D Spinner; Henrik Einwächter; Roland M Schmid; Kathrin Rothe
Journal:  BMC Infect Dis       Date:  2021-04-12       Impact factor: 3.090

9.  Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies.

Authors:  P Kralickova; J Kuhnova; O Soucek; P Vodarek; P Zak; M Simkovic; M Motyckova; L Smolej; E Mala; C Andrys; J Krejsek; V Thon
Journal:  J Immunol Res       Date:  2017-12-17       Impact factor: 4.818

10.  [Cryptococcal meningitis in the treatment of CLL with ibrutinib: a case report and literature review].

Authors:  H Zhang; X H Zhang; P Chen; B Z Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.